KCM Investment Advisors LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.8% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,480 shares of the healthcare conglomerate’s stock after purchasing an additional 758 shares during the quarter. KCM Investment Advisors LLC’s holdings in UnitedHealth Group were worth $11,974,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of UnitedHealth Group by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock valued at $41,755,280,000 after purchasing an additional 544,740 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of UnitedHealth Group by 0.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock valued at $12,893,331,000 after purchasing an additional 94,641 shares during the last quarter. Bank of New York Mellon Corp raised its stake in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after acquiring an additional 35,533 shares during the period. International Assets Investment Management LLC raised its stake in shares of UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after acquiring an additional 5,290,025 shares during the period. Finally, Dimensional Fund Advisors LP raised its stake in shares of UnitedHealth Group by 30.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after acquiring an additional 880,183 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms recently issued reports on UNH. Barclays dropped their price target on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Stephens dropped their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Bank of America decreased their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Finally, Royal Bank of Canada reduced their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $615.53.
UnitedHealth Group Stock Up 0.2 %
UNH stock traded up $1.27 during midday trading on Friday, reaching $594.42. The company had a trading volume of 671,266 shares, compared to its average volume of 3,876,317. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $547.03 billion, a P/E ratio of 38.72, a PEG ratio of 1.78 and a beta of 0.58. The company has a 50 day moving average of $582.95 and a two-hundred day moving average of $548.34.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. During the same quarter in the prior year, the business posted $6.56 EPS. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.41%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- Differences Between Momentum Investing and Long Term Investing
- Top-Performing Non-Leveraged ETFs This Year
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.